Global Pulmonology Pleuroscopy and Tracheostomy Device Market to Reach $24.2 Billion by 2025: In-Depth Analysis of Market Landscape and Growth Potential

Global Market Size and Future Growth Forecast of Interventional Pulmonology and Tracheostomy Devices

Interventional pulmonology and tracheostomy devices represent specialized medical instruments used for diagnostic and therapeutic interventions related to the lungs and airways. Thoracoscopy involves inserting a thin, flexible tube (thoracoscope) through a small incision or natural orifice to observe the pleural cavity surrounding the lungs. This procedure is typically employed to assess pleural effusion, perform biopsies, and treat certain pulmonary diseases. Meanwhile, tracheostomy devices are designed to create a surgical opening in the trachea to establish a direct airway. These devices may include tracheostomy tubes and associated accessories, providing critical respiratory support or secretion clearance. Pulmonologists utilize these tools to perform essential procedures for diagnosing and managing respiratory diseases, ensuring effective patient care and treatment.

According to in-depth research by WENKH, the global market for interventional pulmonology and tracheostomy devices is expected to reach approximately $24.23 billion in 2025. Driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and severe respiratory failure cases, there is a growing clinical demand for precise airway management and early interventional therapies. Healthcare institutions are increasingly investing in advanced interventional pulmonology techniques and tracheostomy equipment to improve emergency response efficiency and patient survival rates, which has accelerated market expansion. The sector is projected to grow at a compound annual growth rate (CAGR) of 7.66%, reaching around $40.61 billion by 2032.

Detailed Product Segmentation and Characteristics

WENKH’s analysis categorizes interventional pulmonology and tracheostomy products by function and application scenarios into bronchoscopes, thoracoscopes, respiratory therapeutic devices, interventional pulmonology (IP) treatment devices, tracheostomy tubes, and other related equipment.

• Bronchoscopes are the most commonly used interventional tools, playing an irreplaceable role in diagnosing and treating pulmonary diseases such as lung cancer screening, foreign body removal, and biopsy sampling. This category has the highest market penetration and shipment volumes.
• Thoracoscopy is mainly utilized for direct visualization and management of pleural diseases, including malignant pleural effusion and tuberculous pleuritis. Its adoption is steadily increasing in specialized hospitals and advanced respiratory centers.
• Respiratory therapeutic devices include airway clearance instruments, cryotherapy, and laser ablation technologies, representing a trend toward minimally invasive, diversified interventional treatments.
• IP treatment devices focus on precise localization and therapy for interstitial lung diseases or malignancies. This segment has high technological barriers and is currently in an early expansion phase.
• Tracheostomy tubes are essential for emergency and long-term ventilation management in ICUs and chronic care facilities, driven by aging populations and increasing respiratory support needs.

The fastest-growing segment is respiratory therapeutic devices, propelled by advancements in non-invasive and minimally invasive technologies and the diverse treatment needs of elderly patients. Frequent product upgrades are accelerating overall market growth.

Downstream Application Fields and Market Demand

Interventional pulmonology and tracheostomy devices find applications mainly in hospitals and clinics, mobile surgical centers, and other healthcare settings.

• Hospitals and clinics remain the primary application venues due to comprehensive medical equipment and skilled healthcare professionals, handling most complex cases with steady demand growth.
• Mobile surgical centers have rapidly expanded by improving healthcare accessibility and flexibility, especially accelerated by the COVID-19 pandemic and urgent medical demands, showing higher growth rates than other venues.
• Other fields such as rehabilitation centers, ambulance medical units, and community health facilities are gradually expanding their use of these devices, promoting diversified medical service delivery.

Hospitals continue to dominate the market, ensuring widespread adoption of these technologies, while mobile surgical centers exemplify innovative healthcare service models that drive further market growth.

Competitive Landscape of Major Global Players

The global interventional pulmonology and tracheostomy market is highly competitive. Leading manufacturers include Boston Scientific, Olympus, Medtronic, Ambu, Pentax (HOYA), Nanwei Medical Technology Co., Ltd., Fujifilm, CONMED, Teleflex Medical, Smiths Medical, Medi-Globe, Merit Medical Systems, TRACOE Medical, Karl Storz, Verathon, Guangzhou Weili Medical Instruments Co., Ltd., and Tuoren Group. The top five companies collectively hold approximately 69% of the market share.

Key players:

1. Boston Scientific (USA): Specializes in interventional medical technologies, including micro-invasive treatment solutions covering cardiovascular, neurological, urological, endoscopic, and oncological interventions. Renowned for stents, catheters, electrophysiology devices, and high-frequency ablation systems widely used in hospitals worldwide.
2. Olympus (Japan): A global leader in medical endoscopy systems, microscopes, and industrial inspection solutions. Olympus’ products dominate gastrointestinal and respiratory endoscopy markets, with continuous innovation in miniaturization and smart imaging technology.
3. Medtronic (Ireland): Offers cardiovascular devices, neurostimulation systems, diabetes management, and surgical instruments globally. Known for pacemakers, vascular stents, and insulin pumps, Medtronic excels in high-risk chronic disease and minimally invasive therapies.
4. Nanwei Medical Technology Co., Ltd. (China): Produces diagnostic and therapeutic endoscopic instruments for gastrointestinal, respiratory, urinary, and hepatobiliary applications. Emphasizes domestic innovation and market expansion, with key consumables like biopsy forceps, stone retrieval baskets, and hemostatic clips.
5. Ambu (Denmark): Focuses on single-use endoscopes, respiratory management products, electrophysiology sensors, and training simulators. A leader in disposable flexible endoscopes, Ambu’s infection control advantages and digital integration strengthen its clinical demand responsiveness.

Regional Market Distribution

The global market exhibits a multi-tiered development landscape:

• North America: Dominated by the USA and Canada, this region leads due to advanced medical technologies and comprehensive respiratory disease intervention systems. High COPD and critical care needs drive extensive adoption of minimally invasive tracheostomy and bronchoscopy devices. North America also serves as a hub for R&D, clinical validation, and global distribution.
• Europe: Countries like Germany, France, the UK, and Nordic nations show steady growth, supported by early intervention philosophies and robust healthcare infrastructure. Europe demands precise and integrated airway management solutions, with strong local manufacturers and international companies collaborating closely with public healthcare systems.
• Asia-Pacific: The fastest-growing market, centered on China, Japan, India, and South Korea. China’s high respiratory disease prevalence, aging population, and ICU expansion fuel demand, with domestic firms rising alongside international players adopting localization strategies. Japan and South Korea maintain high standards for advanced medical equipment and standardized clinical procedures.
• Middle East & Africa: Developing more slowly, some nations are modernizing healthcare, increasing demand in emergency, ICU, and military medical applications. Gulf countries invest heavily in respiratory devices and advanced bronchoscopy systems, supported by distributor networks and remote training.
• Latin America: Focused on Brazil, Mexico, and Argentina, this region sees gradual improvements in healthcare resources and critical care capacity, with public hospitals adopting international standards and brands. Multinational companies expand coverage via local partnerships and regional support teams.

The above data is from the market analysis report "Global Pulmonology Pleuroscopy and Tracheostomy Device Market Size, Competition Landscape and Supply Chain Research Report 2025” released by WENKH. WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.